| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/2002 | WO2002057308A2 Zinc finger polypeptides and their use |
| 07/25/2002 | WO2002057303A2 Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002057299A2 Vegfr-3 binding peptides and their use for inhibiting angiogenesis |
| 07/25/2002 | WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | WO2002057291A2 Hla-dr2 binding peptides |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002057287A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057225A2 Thrombin inhibitors |
| 07/25/2002 | WO2002056916A2 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056904A1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 07/25/2002 | WO2002056903A2 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
| 07/25/2002 | WO2002056902A2 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 07/25/2002 | WO2002056901A2 Cosmetic or pharmaceutical preparations of the treatment of epithelial outer tissue |
| 07/25/2002 | WO2002056900A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 07/25/2002 | WO2002056899A1 Compositions and methods for reducing oxysterols in blood |
| 07/25/2002 | WO2002056897A2 Pharmaceutical for stimulating the regeneration of tissues |
| 07/25/2002 | WO2002056837A2 Inhibition of protein-phosphatases for the treatment of heart failure |
| 07/25/2002 | WO2002056833A2 Preparation of a therapeutic composition |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002056804A2 Presbyopia treatment by lens alteration |
| 07/25/2002 | WO2002040041A3 Orally ingestible preparation of mistletoe lectins and method |
| 07/25/2002 | WO2002038107A3 Stat modulators |
| 07/25/2002 | WO2002033085A9 Wisp polypeptides and therapeutical applications thereof |
| 07/25/2002 | WO2002032941A3 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002030256A3 Diagnostic indicator of thymic function |
| 07/25/2002 | WO2002028439A3 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 07/25/2002 | WO2002024731A3 Regulation of human fgd1-like protein |
| 07/25/2002 | WO2002022792A3 Nucleic acid molecules encoding a poly(adp-ribose) polymerase |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002020466B1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001085940A3 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 07/25/2002 | WO2001078781A9 Methods for prevention and treatment of gastrointestinal disorders |
| 07/25/2002 | WO2001078701A3 Method and compositions for preventing hormone induced adverse effects |
| 07/25/2002 | WO2001077332A3 Compositions and methods related to canine igg and canine il-13 receptors |
| 07/25/2002 | WO2001075093A8 Novel nucleic acids and polypeptides |
| 07/25/2002 | WO2001074346A3 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 07/25/2002 | WO2001072798A3 Regulation of human oatp2-related protein |
| 07/25/2002 | WO2001066721A3 Nucleic acid sensor molecules |
| 07/25/2002 | WO2001064904A3 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 07/25/2002 | WO2001062929A3 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 07/25/2002 | WO2001062289B1 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 07/25/2002 | WO2001060992A3 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001055176A3 Methods for inhibiting smooth muscle cell proliferation |
| 07/25/2002 | WO2001042297A9 Clasp-3 transmembrane protein |
| 07/25/2002 | WO2001039795A9 Attenuation of fibroblast proliferation |
| 07/25/2002 | WO2001035977A9 Attenuation of tumor growth, metastasis and angiogenesis by use of chondroitin sulfate degrading enzymes |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | WO2001025275A9 Regulatory/unfolding peptides of ezrin |
| 07/25/2002 | WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 07/25/2002 | WO2001007056A9 Method of promoting bone growth with hyaluronic acid and growth factors |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001003723A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/25/2002 | WO2001003716A9 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001002001A9 PEPTIDE LIGANDS THAT BIND IgM ANTIBODIES AND BLOCK INTERACTION WITH ANTIGEN |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000811A9 17867, a novel human aminopeptidase |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/25/2002 | US20020099357 Ocular iontophoretic device and method for using the same |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099196 Polypeptide for use in the treatment of cancer and hematopoietic defects |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099188 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2002 | US20020099183 Process for the preparation of neutrophil inhibitory factor |
| 07/25/2002 | US20020099179 Genetically engineered antibodies for use in the treatment of immunological defects |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099177 Human IRAK-2 |
| 07/25/2002 | US20020099176 Antibodies to human g-protein chemokine receptor hdgnr10 (ccr5receptor) |
| 07/25/2002 | US20020099175 Methods for the synthesis of a modified hemoglobin solution |
| 07/25/2002 | US20020099174 Filtration of plasma mixtures using cellulose-based filter aids |
| 07/25/2002 | US20020099172 Endoderm, cardiac and neural inducing factors - xenopus paraxial protocadherin protein |
| 07/25/2002 | US20020099171 Protein for use as antitumor agent |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099093 For use in testing systemic carnitine deficiency |
| 07/25/2002 | US20020099067 Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 07/25/2002 | US20020099046 Atorvastatin or a pharmaceutically acceptable salt thereof and an antihypertensive agent such as a calcium channel blocker, an ACE inhibitor, an A-II antagonist, a diuretic, a beta- or alpha adrenergic receptor blocker |
| 07/25/2002 | US20020099042 Treating IL-1 mediated disease, autoimmune disease, inflammatory disease and neurodegenerative disease with ICE inhibitors characterized by specific structural and physicochemical features. |
| 07/25/2002 | US20020099041 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 07/25/2002 | US20020099040 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 07/25/2002 | US20020099033 Method and composition for treating sleep apnea |
| 07/25/2002 | US20020099029 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099025 Treatment of neurological disorders |
| 07/25/2002 | US20020099018 Dissolving an oligopeptide, such as Bombesin-Antagonist, Protirelin, Somatostatin and Cetrorelix, in acetic acid; transferring the solution to water, and lyophilizing; treating female infertility; gonad protection |